PR Newswire (press release) MADRID, June 13, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the results from the CONCERTO trial, the first randomized, controll...
Healio Nearly half of patients with Crohn's disease treated with methotrexate after poor response to thiopurines experienced sustained clinical benefit with relatively few and mild adverse events in a recent study. Researchers assessed the tolerability and ...
Big News Network.com As first-line treatment, EULAR recommends rheumatologists administer methotrexate (MTX) or combination therapy of MTX with other conventional synthetic DMARDs. Low-dose glucocorticoids should also be considered in combination with DMARDs for .
Castanet.net Forty-year-old Brenda Gaida died in 2007 when she was given excessive doses of methotrexate , a drug that can be used to treat cancer patients, at Vernon's Jubilee Hospital for a pre-existing skin condition while on vacation with her family. According ... and more »
Toronto NewsFIX Researchers at the University of Maastricht in The Netherlands have been comparing the combination of etanercept and methotrexate (the conventional treatment for RA) with etanercept alone and methotrexate alone. Of the 682 patients in the trial, 80 per ... and more »
PR Newswire (press release) MADRID, June 13, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the results from the CONCERTO trial, the first randomized, controll...
Healio Nearly half of patients with Crohn's disease treated with methotrexate after poor response to thiopurines experienced sustained clinical benefit with relatively few and mild adverse events in a recent study. Researchers assessed the tolerability and ...
Castanet.net Forty-year-old Brenda Gaida died in 2007 when she was given excessive doses of methotrexate , a drug that can be used to treat cancer patients, at Vernon's Jubilee Hospital for a pre-existing skin condition while on vacation with her family. According ... and more »
Rheumatology Update Reporting in JAMA Internal Medicine the authors from Stockholm's Karolinska Institutet said their findings showed early aggressive treatment of patients who had not achieved low disease activity with methotrexate “not only stops the trend of increasing ...
